title: Getting to value in neurological care: a roadmap for academic neurology.
abstract: Academic neurology is undergoing transformational changes. The public investment in biomedical research and clinical care is enormous and there is a growing perception that the return on this huge investment is insufficient. Hospitals, departments, and individual neurologists should expect more scrutiny as information about their quality of care and financial relationships with industry are increasingly reported to the public. There are unprecedented changes occurring in the financing and delivery of health care and research that will have profound impact on the mission and operation of academic departments of neurology. With the passage of the Patient Protection and Affordable Care Act (PPACA) there will be increasing emphasis on research that demonstrates value and includes the patient's perspective. Here we review neurological investigations of our clinical and research enterprises that focus on quality of care and comparative effectiveness, including cost-effectiveness. By highlighting progress made and the challenges that lie ahead, we hope to create a clinical, educational, and research roadmap for academic departments of neurology to thrive in today's increasingly regulated environment.
authors.affiliation: Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA. robert_holloway@urmc.rochester.edu
authors.forename: Robert G
authors.initials: RG
authors.lastname: Holloway
authors.forename: Steven P
authors.initials: SP
authors.lastname: Ringel
mesh_terms: D035843:Biomedical Research; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics / Q000379:methods* / Q000706:statistics & numerical data; D006801:Humans; D009462:Neurology / Q000191:economics / Q000379:methods / Q000706:statistics & numerical data; D017063:Outcome Assessment, Health Care; D058991:Patient Protection and Affordable Care Act